Esophageal dilatation

Digestive Diseases
T T Nostrant

Abstract

Esophageal dilatation as a treatment option in patients with both benign and malignant esophageal strictures is described. Types of dilators available, techniques of passage, complications, redilation rates, and comparative studies between dilating systems are reviewed. The use of proton pump inhibitors to reduce the rates of redilation is discussed in view of the natural history of benign esophageal strictures. Comparisons among blind passage, fluoroscopic guidance and endoscopically directed dilatation are made and discussed in relation to cost effectiveness. Brief mention of new dilating systems including wall stents and wall-tension-sensing systems are made. Achalasia treatment with pneumatic dilatation is described in detail and compared to medication and surgical myotomy options. New treatments, including botulinum toxin injection into the lower esophageal sphincter, are briefly mentioned.

Citations

Mar 1, 2012·American Journal of Physiology. Gastrointestinal and Liver Physiology·Parm MaviAnil Mishra
Dec 18, 2013·Gastrointestinal Endoscopy·Shabana F PashaBrooks Cash
May 11, 1999·The American Journal of Gastroenterology·A PopaS Gleich
Aug 1, 1997·The Australasian Journal of Dermatology·L J WarrenJ D Wilkinson
Aug 8, 2015·Current Opinion in Gastroenterology·Shayan Irani, Richard A Kozarek
Aug 30, 2019·Khirurgiia·E V KirakosyanE Yu Dyakonova

❮ Previous
Next ❯

Related Concepts

Related Feeds

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

© 2021 Meta ULC. All rights reserved